RankingsPricing
  1. US-listed companies
  2. IONIS PHARMACEUTICALS INC
  3. Financials
  4. Cash and cash equivalents

IONIS PHARMACEUTICALS INCIONS

Market cap
$12.4B
P/E ratio
SummaryFinancials
Period EndCash and cash equivalents (Million USD)YoY (%)
Dec 31, 2024242-39.37%
Dec 31, 2023399+44.41%
Dec 31, 2022276-68.19%
Dec 31, 2021869+118.57%
Dec 31, 2020398-41.80%
Dec 31, 2019683+145.06%
Dec 31, 2018279+115.09%
Dec 31, 2017130+53.07%
Dec 31, 201685-34.25%
Dec 31, 2015129-9.93%
Dec 31, 2014143-10.61%
Dec 31, 2013160+28.51%
Dec 31, 2012124+90.12%
Dec 31, 201165-6.53%
Dec 31, 201070

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)